| About the author: |
I. M. Skrypnyk, G. S. Maslova, T. V. Lymanets |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Obesity is one of the proven risk factors for all types of tumors and is one of the reasons for reducing the effectiveness of specific chemotherapy and the development of chemotherapy-induced injury of liver. This article presents the results of functional liver state monitoring in patients with acute lymphoblastic leukemia during remission induction chemotherapy, taking into account the overweight and obesity. High toxicity of acute lymphoblastic leukemia chemotherapy regimens with a general tendency to hypoproteinemia development has been demonstrated. The overweight and obesity potentiate cytostatic-induced liver injury in patients with acute lymphoblastic leukemia with maximum risk in case of primary liver injury due to tumor exposure. |
| Tags |
acute lymphoblastic leukemia, obesity, chemotherapy, L-asparaginase, liver injury |
| Bibliography |
- Alachkar H, Fulton N, Sanford B, Malnassy G, Mutonga M, Larson RA, et al. Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia. Pharmacogenomics Journal. 2017;17(3):274–9. doi: 10.1038/tpj.2016.7
- Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348(17):1625–38.
- Castillo JJ, Reagan JL, Ingham RR, Furman M, Dalia S, Merhi B, et al. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res. 2012; 36(7):868–75. doi: 10.1016/j.leukres.2011.12.020
- Chiaretti S, Zini G, Bassan R. Diagnosis and subclassification of acute lymphoblastic leukemia. Mediterr J Hematol Infect Dis. 2014;6:e2014073.
- De Santo C, Booth S, Vardon A, Cousins A, Tubb V, Perry T, et al. The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100. Int J Cancer. 2018;142(7):1490–502. doi: 10.1002/ijc.31170.
- Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2012;30(13):1553–61. doi: 10.1200/JCO.2011.39.9436.
- Ehsanipour EA, Sheng X, Behan JW, Wang X, Butturini A, Avramis VI, et al. Adipocytes cause leukemia cell resistance to L-Asparaginase via release of glutamine. Cancer Res. 2013;73(10):2998–3006. doi: 10.1158/0008-5472.CAN-12-4402.
- Hoelzer D, Bassan R, Dombret H, Fielding A, Ribera JM, Buske C, et al. Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5): 69–82. doi: 10.1093/annonc/mdw025.
- Lin A , Othus M, McQuary A, Chi M, Estey E. Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia. Leuk Lymphoma. 2013;54(3):541–6. doi: 10.3109/10428194.2012.717278
- Maslova G, Skrypnyk I, Lymanets T. The role of arginine/citrulline cycle disorders in the liver injury pathogenesis in acute myeloid leukemia patients with concomitant obesity. Annals of Oncology journal.2020 (31), S4: S655–656. DOI:10.1016/j.annonc.2020.08.022
- Orgel E, Mueske NM, Sposto R, Gilsanz V, Freyer DR, Mittelman SD. Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy. Leuk Lymphoma. 2018;59(1):138–45. doi: 10.3109/10428194.2015.1136741.
- Orgel E, Sea JL, Mittelman SD. Mechanisms by Which Obesity Impacts Survival from Acute Lymphoblastic Leukemia. J Natl Cancer Inst Monogr. 2019; 2019(54):152–6. doi: 10.1093/jncimonographs/lgz020
- Skrypnyk I, Maslova G. The Overweight role in the occurrence of hepatotoxic reactions during chemotherapy of acute leukemia. Sharing the future of digestive health. UEG Week. 2018; Abstr. of the 26 UEGW (October, 20-24, 2018); Vienna, Austria. 2018; 401–2. DOI:10.1016/S0618-8278(19)30842-4
- Sheng X, Mittelman SD. The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia. Front Pediatr. 2014; 2:53. doi: 10.3389/fped.2014.00053
- Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy – associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007; 94(3):274–86. doi: 10.1002/bjs.5719.
|
| Publication of the article |
«World of Medicine and Biology» №2(80), 2022 year, 146-150 pages, index UDK (616.36:616.155.392)-056.5 |
| DOI |
10.26724/2079-8334-2022-2-80-146-150 |
